Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-051189
Filing Date
2005-03-15
Accepted
2005-03-15 16:59:37
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 1000822
2 SUBTENANT NON-DISTURBANCE AND SUBSTITUTE LEASE AGREEMENT dex108.htm EX-10.8 38082
3 FIRST AMENDMENT TO SUBSTITUTE LEASE AGREEMENT dex109.htm EX-10.9 29801
4 SUBSIDIARIES dex21.htm EX-21 3961
5 CONSENT OF ERNST & YOUNG LLP dex23.htm EX-23 1836
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7822
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7814
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2930
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2928
  Complete submission text file 0001193125-05-051189.txt   1098751
Mailing Address PO BOX 13989 RESEARCH TRIANGLE PK NC 27709
Business Address 1040 SWABIA COURT DURHAM NC 27703 9199415185
EMBREX INC /NC/ (Filer) CIK: 0000878725 (see all company filings)

EIN.: 561469825 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19495 | Film No.: 05682340
SIC: 2836 Biological Products, (No Diagnostic Substances)